On September 15, Needham ***** yst James Ricchiuti lifted the firm's price target on Teledyne Technologies Incorporated (NYSE:TDY) to $760 from $750, and reiterated a Buy rating. The revised price target reflected an upside of 27% from the close of the note.
According to TipRanks, the ***** yst told investors that the company was well placed to gain from a broadening short cycle recovery and opportunities in modern defense applications. Needham further added that the stock offers a 2.6-to-1 risk/reward skew at current levels.
The adjustment is largely in line with the broader ***** yst community. As of the close on September 16, TDY is a Moderate Buy based on the consensus of 10 ***** ysts. It has a one-year average share price target of $758.20, representing an upside of 26%.
Needham noted 'broadening' improvements in the company's short cycle businesses, which suggests that momentum is spreading across product lines, rather than being limited to any one particular segment.
During the Q2 earnings call, the management noted that short-cycle commercial markets were beginning to show growth inflections after recent headwinds and lifted its short-cycle portfolio's growth outlook to mid-single-digits for the year, up from earlier estimates of flat to low-single-digit growth.

#cycle #september

Once upon a time, the 'space race' meant the grand strategic competition between the USA and the USSR to gain control of the heavens. The superpowers designed and built satellites, manned capsules, orbital **** ecraft and long-endurance **** e stations, and NASA even sent the Apollo landers to put men on the Moon.
Today, the **** e race is heating up again, but in a very different way. Yes, the governments are still involved – NASA's Artemis program is targeting the Moon, the Russians have a Soyuz escape ship docked at the International **** e Station, and other powers such as the EU, China, and India have large-scale **** e programs. But the real difference – and a lot of the innovation – is coming from commercial players working alongside government **** e agencies.
This past summer, Elon Musk's **** eX went public, in Wall Street's largest ever IPO. The company is pioneering reusable large rockets, and has already made history with privately launched and/or publicly funded missions of the Falcon 9 rocket and Crew Dragon capsule.
Promotion
55% Off TipRanks

#once

Ask any old-school market investor and he'll tell you that the cliché is true, and 'past performance cannot guarantee future returns.' If that were true without exception, then growth investing would not be a viable option – but we all know that investors love to buy into stocks that have shown enormous growth in recent months. The 'monster growth' stocks are popular because investing into them is successful.
The key is understanding the smart middle way, and treating stocks as individuals, with idiosyncratic features that need to be taken case by case. Past performance can be a solid indicator, even if it's not a guarantee, and when it's paired with consistent long-term gains, it's a powerful indicator indeed.
You can double check that by checking in with the Wall Street **** ysts, the professional stock experts who've built careers and reputations on the quality of their published **** yses. And right now, some of Wall Street's pros are saying that the growth stocks are not done climbing.
Promotion
55% Off TipRanks

#performance

Wall Street is fairly bullish on ****** eX (SPCX) stock, and Oppenheimer's latest price target raise is pushing that narrative further.
Oppenheimer ****** yst Timothy Horan increased his price target on ****** eX stock to $280 from $250, according to TipRanks. His price target implies about 87% upside, as ****** eX is trading near $150. The raise is a result of Horan's growing confidence that ****** eX can become a real AI giant.
On the surface, MarketBeat's data shows 27 of 42 ****** ysts covering the stock rate ****** eX a buy, and this fresh take from Oppenheimer makes the stock look very attractive.
The stock closed 6.42% higher following this ****** yst call. But does the thesis make sense?
The core valuation question is whether you believe that it can capture the market it said it aspires to capture in its S-1. ****** eX's S-1 states that the company estimates its total addressable market (TAM) at $28.5 trillion, of which $26.5 trillion, or 92.98%, is expected to come from AI.

#price #capture

AI is soaking up the headlines these days, but the cloud, while older news, remains a powerful force in the tech industry. Cloud services, such as AWS and Azure, are true giants, with many millions of subscribers and tens of billions in revenue. At the same time, the cloud, like AI, has been powering the rapid expansion of data centers.
Some numbers tell the tale. In 2025, per Markets and Markets, the cloud computing sector was valued at nearly $1.295 trillion. That's impressive, but it's also growing quickly, and is expected to reach $2.281 trillion as early as 2030, for a 12% CAGR through the forecast period.
Growth on that scale always generates solid investment opportunities, and the eye will naturally be drawn to the cloud giants. But Wall Street's **** ysts are reminding us of a basic truth in the stock game: that there are sound investments at every scale. They're saying to look under the radar, where we can find overlooked stocks that offer plenty of potential.
Promotion
55% Off TipRanks

#trillion #scale #wall

Wall Street's biggest bank just delivered a message that sounds contradictory at first. Chip stocks could fall further from here, and that is not necessarily bad news, according to one of the sector's most closely watched **** ysts.
The call came two days before Nvidia reported earnings on Aug. 26. Nvidia beat on every key metric and guided ahead of consensus for Q3. But what Bank of America was telling investors going into that report was more nuanced than a simple read on the earnings print.
Bank of America **** yst Vivek Arya, who ranks 229 out of more than 12,000 **** ysts tracked by TipRanks with a 58% success rate, sees roughly 10% further downside risk for the Philadelphia Semiconductor Index (SOX).
A decline of that size would push the SOX back to its valuation discount versus the S&P 500 before ChatGPT's debut in November 2022, CNBC reported.
Several factors are weighing on the group in the near term. Arya pointed to rising interest rates, public pushback on data center projects, geopolitical tension, worries over circular financing arrangements between AI companies, and heavy investor positioning, with chips now running about 13% overweight against the broader S&P 500.

#analysts

Wall Street has spent much of 2026 debating whether AMD is an Nvidia alternative or a genuinely different bet. On Aug. 25, one of the Street's higher-ranked chip ******* ysts made his position clear.
AMD shares jumped roughly 4% on the day. The upgrade came with a specific argument about where server chip revenue is headed that goes well beyond the usual AI trade.
Simon Leopold, Raymond James' semiconductor ******* yst, upgraded AMD to Strong Buy from Outperform and raised his price target to $641 from $565 on Aug. 25, implying roughly 40% upside from AMD's closing price that day, CNBC reported.
Leopold ranks 120th out of 12,496 ******* ysts tracked by TipRanks, with a 60% success rate and an average return of 30% per rating. His $641 target sits above the consensus average of roughly $613 across all ******* ysts covering AMD.
Read more AMD:

#leopold

Phillip Securities ****** yst Glenn Thum recently set a target price of $75 per share for ****** e Exploration Technologies (NASDAQ: SPCX). As of the time of this writing, that would amount to a 45% decline in the stock price. Moreover, Thum has a five-star rating on TipRanks and an 87% success rate, which has won him considerable credibility.
Admittedly, only two out of 35 ****** ysts rate ****** eX as a sell, and certainly, such forecasts do not always come to pass. Nonetheless, it highlights some risks with owning ****** eX stock.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Here's why investors would probably serve themselves well by heeding this warning.
Thum pointed out a few reasons for his negative outlook on this company. He noted its capital expenditures (capex), which now amount to approximately 2.4 times ****** eX's revenue in the second quarter of 2026. Additionally, Thum expressed some discomfort with 19.5% of Q2 group revenues coming from a single AI customer, widely believed to be Anthropic.

#thum #Stock

One of the hotter stocks in big healthcare just now is pharmacy chain mainstay CVS Health (NYSE: CVS). The company's shares have raced more than 18% higher year to date, comparing favorably to the benchmark S&P 500 index's sub-13% rise.
And, according to most **** ysts tracking the stock, the stock's not done yet. According to data compiled by TipRanks, the consensus pundit price target is $114.59 per share, which is 22% above its most recent closing level.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Let's open the doors of this busy pharmacy to determine how it got here, and whether it can indeed continue to move higher.
Any company that delivers two estimates-crushing quarters in a row is going to be a juicy buy candidate for investors. In all three of the quarterly earnings reports that CVS published this calendar year, it topped consensus **** yst estimates for revenue and profitability. Investors are more impressed by the latter, naturally, so the company looked particularly good with its convincing beats in both the first and second frames.

#NVIDIA #signal #company #higher

One of the hotter stocks in big healthcare just now is pharmacy chain mainstay CVS Health (NYSE: CVS). The company's shares have raced more than 18% higher year to date, comparing favorably to the benchmark S&P 500 index's sub-13% rise.
And, according to most ****** ysts tracking the stock, the stock's not done yet. According to data compiled by TipRanks, the consensus pundit price target is $114.59 per share, which is 22% above its most recent closing level.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Let's open the doors of this busy pharmacy to determine how it got here, and whether it can indeed continue to move higher.
Any company that delivers two estimates-crushing quarters in a row is going to be a juicy buy candidate for investors. In all three of the quarterly earnings reports that CVS published this calendar year, it topped consensus ****** yst estimates for revenue and profitability. Investors are more impressed by the latter, naturally, so the company looked particularly good with its convincing beats in both the first and second frames.

#continue #pharmacy

There's a concept in biology called adaptive radiation. It occurs when a species enters a new environment with unoccupied ecological niches and rapidly evolves into multiple distinct forms. We see a similar pattern in technology. When a breakthrough technology emerges, it often triggers a wave of innovation, with a growing number of companies developing competing approaches and quickly filling what was previously an empty market.
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Quantum computing appears to be following a similar path. The technology is still in its early stages, and a few companies are already racing to bring it into commercial reality, each pursuing different architectures and strategies. Unlike traditional computers, which process information as ones and zeros, quantum computers use quantum bits, or qubits, that can represent multiple states simultaneously. That allows them to tackle certain highly complex calculations much faster than conventional computers.
The commercial potential is hard to ignore, with Grand View Research projecting the quantum computing market will expand from about $1.9 billion in 2026 to more than $8 billion by 2033.

#quantum #tipranks #computing

There's a concept in biology called adaptive radiation. It occurs when a species enters a new environment with unoccupied ecological niches and rapidly evolves into multiple distinct forms. We see a similar pattern in technology. When a breakthrough technology emerges, it often triggers a wave of innovation, with a growing number of companies developing competing approaches and quickly filling what was previously an empty market.
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Quantum computing appears to be following a similar path. The technology is still in its early stages, and a few companies are already racing to bring it into commercial reality, each pursuing different architectures and strategies. Unlike traditional computers, which process information as ones and zeros, quantum computers use quantum bits, or qubits, that can represent multiple states simultaneously. That allows them to tackle certain highly complex calculations much faster than conventional computers.
The commercial potential is hard to ignore, with Grand View Research projecting the quantum computing market will expand from about $1.9 billion in 2026 to more than $8 billion by 2033.

#computers #market #investing

This article was originally published on ETFTrends.com.
In my former career as a stock research ******* yst, a unique dynamic always signaled a high-conviction idea. While I sat there building out earnings models and reworking valuation ******* umptions, the technical ******* ysts would look for relative strength or weakness. The chartists would regularly poke holes in my fundamental ******* ysis recommendations. However, occasionally, my research would independently flag an undervalued stock that the technical ******* ysis supported as a breakout. The recently launched Defiance KSM TipRanks ******* yst ETF (RANK) brings these two investment approaches together nicely. The new index ETF can act as a bridge that blends fundamental research and momentum investing.
The newly launched RANK ETF blends fundamental ******* ysis and technical trends in one TipRanks index approach.
Risk management constraints keep individual stock weights capped at 6% and Walmart (WMT) was a recent top position.
RANK's underlying TipRanks index outpaced standalone strategies over a trailing three-year stretch, achieving a 37% annualized return as of June 2026.

I covered Wells Fargo's AMD upgrade at the start of July, making a specific case that the server CPU story was being underappreciated relative to the GPU narrative. On July 5, 57-year-old Goldman Sachs also made the same argument louder and with a bigger number.
Goldman Sachs ******* yst James Schneider raised the firm's 12-month price target on Advanced Micro Devices (AMD), maintaining a Buy rating, according to the firm's note shared with TheStreet. The upgrade represents a 42% increase in the price target on a stock that is already up 157.77% year-to-date, as of this writing.
AMD closed July 6 at $552.05, up 6.61% on the session, with a market cap of $900 billion, according to Yahoo Finance. The $640 target implies roughly 16% further upside from that close.
Schneider ranks 289th out of 12,355 Wall Street ******* ysts on TipRanks with a 64% success rate. Again, his call is not a momentum chase but a structural thesis about what agentic Artificial Intelligence (AI) means for CPU demand.
Also Read: History of AMD: Timeline and Facts

Fox (FOX) just made the biggest move of its post-Disney era, agreeing to buy Roku for roughly $22 billion.
But the stock fell sharply the day the deal landed and kept sliding the next session, pushing Fox shares to a fresh 52-week low.
Now one of Wall Street's most followed **** ysts has weighed in, and her verdict gives cautious shareholders something to watch.
Bank of America Securities **** yst Jessica Reif Ehrlich kept her sell rating on Fox and nudged her price target up to $54, as reported by TipRanks.
Ehrlich's target tells investors what to watch. It sits just above where Fox's more widely traded Class A shares closed and above the battered Class B stock, making this a verdict on the absence of near-term catalysts, not a call for more downside.